Literature DB >> 19424751

The role of the platelet-rich plasma in accelerating the wound-healing process and recovery in patients being operated for pilonidal sinus disease: preliminary results.

Michail Spyridakis1, Gregory Christodoulidis, Constantine Chatzitheofilou, Dimitris Symeonidis, Konstantinos Tepetes.   

Abstract

BACKGROUND: Because of the poor quality of life that results from the open technique (open excision and packing) for surgically treating pilonidal cyst disease, several alternatives that accelerate the wound-healing process have been proposed. This study aimed to evaluate the effect of platelet-derived growth factors on the healing process.
METHODS: Fifty-two patients with pilonidal sinus disease who underwent open excision and secondary closure of the surgical wound (n = 22) or additional local postoperative infusion of platelet-derived growth factors (n = 30) were evaluated. Duration of total wound healing and time to return to normal activities were evaluated. Quality of life of patients in each group was assessed via a stabilized questionnaire.
RESULTS: Wound-healing rates were much greater for the platelet group (p < 0.01). Complete healing of the surgical wound required 24 days for the platelet group while the respective time for the control group was more than 30 days (p < 0.01). Patients in the platelet group returned to their normal activities around the postoperative day 17 when mean wound volume was about 10 cc, while control group patients managed to do so around the postoperative day 25.
CONCLUSIONS: These data provide evidence that the use of platelet-derived growth factors directly to the surgical wound enhances the healing process resulting in faster recovery of patients surgically treated for pilonidal sinus disease.

Entities:  

Mesh:

Year:  2009        PMID: 19424751     DOI: 10.1007/s00268-009-0046-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  26 in total

1.  The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery.

Authors:  D Man; H Plosker; J E Winland-Brown
Journal:  Plast Reconstr Surg       Date:  2001-01       Impact factor: 4.730

Review 2.  The use of autologous platelet-leukocyte gels to enhance the healing process in surgery, a review.

Authors:  P A Everts; E P Overdevest; J J Jakimowicz; C J Oosterbos; J P Schönberger; J T Knape; A van Zundert
Journal:  Surg Endosc       Date:  2007-04-13       Impact factor: 4.584

3.  Is wide local excision for pilonidal disease still justified?

Authors:  Talar Tejirian; Jenny J Lee; Maher A Abbas
Journal:  Am Surg       Date:  2007-10       Impact factor: 0.688

4.  A review of three popular methods of treatment of postanal (pilonidal) sinus disease.

Authors:  M J Notaras
Journal:  Br J Surg       Date:  1970-12       Impact factor: 6.939

5.  Antimicrobial peptides from human platelets.

Authors:  Yi-Quan Tang; Michael R Yeaman; Michael E Selsted
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Karydakis flap repair for sacrococcygeal pilonidal sinus disease: how important is technique?

Authors:  Anil Keshava; Christopher J Young; Matthew J F X Rickard; Gael Sinclair
Journal:  ANZ J Surg       Date:  2007-03       Impact factor: 1.872

7.  The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

Authors:  C A McHorney; J E Ware; A E Raczek
Journal:  Med Care       Date:  1993-03       Impact factor: 2.983

Review 8.  Sacrococcygeal pilonidal sinus: historical review, pathological insight and surgical options.

Authors:  S Chintapatla; N Safarani; S Kumar; N Haboubi
Journal:  Tech Coloproctol       Date:  2003-04       Impact factor: 3.781

Review 9.  Healing by primary versus secondary intention after surgical treatment for pilonidal sinus.

Authors:  I McCallum; P M King; J Bruce
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

10.  Patient characteristics and symptoms in chronic pilonidal sinus disease.

Authors:  K Søndenaa; E Andersen; I Nesvik; J A Søreide
Journal:  Int J Colorectal Dis       Date:  1995       Impact factor: 2.571

View more
  16 in total

1.  Pilonidal disease.

Authors:  Amit Khanna; John L Rombeau
Journal:  Clin Colon Rectal Surg       Date:  2011-03

2.  The treatment of pilonidal disease: guidelines of the Italian Society of Colorectal Surgery (SICCR).

Authors:  D Segre; M Pozzo; R Perinotti; B Roche
Journal:  Tech Coloproctol       Date:  2015-09-16       Impact factor: 3.781

3.  Role of platelet-rich plasma in accelerating the wound-healing process and recovery in patients undergoing operation for pilonidal sinus disease: preliminary results.

Authors:  Jonathan Efron
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

4.  Use of platelet-rich plasma to facilitate wound healing.

Authors:  Yuliya Menchisheva; Ulmeken Mirzakulova; Rudolf Yui
Journal:  Int Wound J       Date:  2018-11-15       Impact factor: 3.315

5.  Crystallized phenol treatment of pilonidal disease improves quality of life.

Authors:  Omer Topuz; Selim Sözen; Mustafa Tükenmez; Sezgin Topuz; Umit Erkan Vurdem
Journal:  Indian J Surg       Date:  2012-06-29       Impact factor: 0.656

6.  Sinotomy technique versus surgical excision with primary closure technique in pilonidal sinus disease.

Authors:  Seyfi Emir; Omer Topuz; Burhan Hakan Kanat; Ilhan Bali
Journal:  Bosn J Basic Med Sci       Date:  2014-11-12       Impact factor: 3.363

7.  Endoscopic pilonidal sinus treatment (E.P.Si.T.).

Authors:  P Meinero; L Mori; G Gasloli
Journal:  Tech Coloproctol       Date:  2013-05-17       Impact factor: 3.781

8.  Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis.

Authors:  Marissa J Carter; Carelyn P Fylling; Laura K S Parnell
Journal:  Eplasty       Date:  2011-09-15

9.  Investigating the effect of autologous platelet-rich plasma on pain in patients with pilonidal abscess treated with surgical removal of extensive tissue.

Authors:  Mostafa Mehrabi Bahar; Mohsen Ali Akbarian; Ali Azadmand
Journal:  Iran Red Crescent Med J       Date:  2013-11-05       Impact factor: 0.611

10.  Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function.

Authors:  Yin Hu; Shan-Shan Rao; Zhen-Xing Wang; Jia Cao; Yi-Juan Tan; Juan Luo; Hong-Ming Li; Wei-She Zhang; Chun-Yuan Chen; Hui Xie
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.